Healthcare provider profile · identity verified

Timothy E. Paul, MD

Family Practice · MOUNT PLEASANT, NC · NPI 1831480268

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	579	128
Amlodipine Besylate	Amlodipine Besylate	475	111
Lisinopril	Lisinopril	433	104
Omeprazole	Omeprazole	355	81
Gabapentin	Gabapentin	309	66
Trazodone Hcl	Trazodone Hcl	285	63
Levothyroxine Sodium	Levothyroxine Sodium	276	66
Metoprolol Succinate	Metoprolol Succinate	268	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	264	44
Furosemide	Furosemide	258	61
Pravastatin Sodium	Pravastatin Sodium	250	66
Pantoprazole Sodium	Pantoprazole Sodium	228	53
Hydrochlorothiazide	Hydrochlorothiazide	210	53
Glipizide Er	Glipizide	208	38
Losartan Potassium	Losartan Potassium	207	48
Eliquis	Apixaban	204	37
Duloxetine Hcl	Duloxetine Hcl	200	38
Buspirone Hcl	Buspirone Hcl	190	37
Metoprolol Tartrate	Metoprolol Tartrate	190	41
Tramadol Hcl	Tramadol Hcl	189	49
Fluticasone Propionate	Fluticasone Propionate	179	56
Simvastatin	Simvastatin	171	31
Metformin Hcl Er	Metformin Hcl	158	31
Zolpidem Tartrate	Zolpidem Tartrate	157	21
Alprazolam	Alprazolam	156	19
Montelukast Sodium	Montelukast Sodium	152	32
Metformin Hcl	Metformin Hcl	149	38
Albuterol Sulfate Hfa	Albuterol Sulfate	147	41
Escitalopram Oxalate	Escitalopram Oxalate	145	26
Tamsulosin Hcl	Tamsulosin Hcl	137	40
Tizanidine Hcl	Tizanidine Hcl	133	28
Potassium Chloride	Potassium Chloride	127	22
Clonazepam	Clonazepam	125	19
Clopidogrel	Clopidogrel Bisulfate	124	29
Sertraline Hcl	Sertraline Hcl	120	28
Jardiance	Empagliflozin	119	22
Fluoxetine Hcl	Fluoxetine Hcl	113	27
Prednisone	Prednisone	113	80
Celecoxib	Celecoxib	111	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	108	18
Meloxicam	Meloxicam	108	26
Pregabalin	Pregabalin	106	23
Rosuvastatin Calcium	Rosuvastatin Calcium	100	27
Lovastatin	Lovastatin	99	20
Warfarin Sodium	Warfarin Sodium	97	22
Famotidine	Famotidine	96	23
Isosorbide Mononitrate Er	Isosorbide Mononitrate	94	14
Alendronate Sodium	Alendronate Sodium	93	18
Citalopram Hbr	Citalopram Hydrobromide	91	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	18
Lorazepam	Lorazepam	89	13
Venlafaxine Hcl Er	Venlafaxine Hcl	89	23
Mirtazapine	Mirtazapine	84	22
Topiramate	Topiramate	84	20
Trulicity	Dulaglutide	80	12
Doxycycline Hyclate	Doxycycline Hyclate	78	66
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	73	13
Spironolactone	Spironolactone	72	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	71	17
Ozempic	Semaglutide	69	suppressed
Donepezil Hcl	Donepezil Hcl	67	13
Carvedilol	Carvedilol	66	15
Bupropion Xl	Bupropion Hcl	65	16
Atenolol	Atenolol	63	13
Diazepam	Diazepam	63	11
Xarelto	Rivaroxaban	63	12
Diclofenac Sodium	Diclofenac Sodium	60	24
Ezetimibe	Ezetimibe	59	18
Januvia	Sitagliptin Phosphate	59	suppressed
Allopurinol	Allopurinol	58	15
Cephalexin	Cephalexin	58	50
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	49	13
Esomeprazole Magnesium	Esomeprazole Magnesium	48	13
Hydralazine Hcl	Hydralazine Hcl	48	11
Ventolin Hfa	Albuterol Sulfate	47	suppressed
Propranolol Hcl	Propranolol Hcl	45	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	42	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	34
Azithromycin	Azithromycin	39	31
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	38	suppressed
Lansoprazole	Lansoprazole	38	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Naproxen	Naproxen	35	suppressed
Ondansetron Hcl	Ondansetron Hcl	34	18
Torsemide	Torsemide	34	suppressed
Finasteride	Finasteride	33	suppressed
Irbesartan	Irbesartan	33	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Tresiba Flextouch U-100	Insulin Degludec	31	suppressed
Azelastine Hcl	Azelastine Hcl	30	12
Clonidine Hcl	Clonidine Hcl	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Linzess	Linaclotide	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	26	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Fluconazole	Fluconazole	23	16
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Belsomra	Suvorexant	20	suppressed
Fentanyl	Fentanyl	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Glipizide	Glipizide	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Nitroglycerin	Nitroglycerin	19	11
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Telmisartan	Telmisartan	19	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	18	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Flecainide Acetate	Flecainide Acetate	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Dexlansoprazole Dr	Dexlansoprazole	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Baclofen	Baclofen	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Ramelteon	Ramelteon	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Digoxin	Digoxin	15	suppressed
Lactulose	Lactulose	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Cefdinir	Cefdinir	14	13
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Xtampza Er	Oxycodone Myristate	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Tramadol Hcl Er	Tramadol Hcl	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Desloratadine	Desloratadine	12	suppressed
Enulose	Lactulose	12	suppressed
Etodolac	Etodolac	12	suppressed
Exemestane	Exemestane	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Liothyronine Sodium	Liothyronine Sodium	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Primidone	Primidone	12	suppressed
Ramipril	Ramipril	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error